Clinical Trial Update: Decidual Stromal Cells to Treat Graft-vs-Host Disease After Stem Cell Transplant for Myelodysplastic Syndrome/Myeloproliferative Neoplasm [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating decidual stromal cells for treatment of steroid-refractory graft-versus-host disease after allogeneic stem cell transplant in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndrome
• Myeloproliferative Neoplasm
• Steroid-refractory Graft-versus-host Disease

Drugs mentioned

• Decidual stromal cells

Snippet

Sponsor: University Health Network, Toronto | Conditions: Myelodysplastic/Myeloproliferative Neoplasm, Steroid Refractory GVHD | Phase 2 | Status: COMPLETED